An article about I Peace was published in the Nikkei, a leading business newspaper in Japan with about 3 million readerships, on March 22, 2021. The article introduced the collaboration with Avery Therapeutics and our Clinical-grade iPS Cell production and banking service for individuals. The article also mentioned that our cell manufacturing facility is licensed by the Ministry of Health, Labor and Welfare (MHLW) of Japan to manufacture and process clinical-grade cells. Moreover, it mentioned that  an independent certifying body acknowledged that the facility is in compliance with the guidelines of the U.S. Food and Drug Administration (FDA).

https://www.nikkei.com/article/DGXZQODZ24A2Z0U0A221C2000000/